PPARG and non-small cell lung carcinoma: Moreover, Sun et al. found that nicotine-induced NSCLC cell proliferation was partly mediated through alpha4 nAChR, which could be blocked by rosiglitazone through activating the ERK/p38 MAPK/p53 signaling pathway in a PPARγ-independent manner [96].